Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults. A pilot study

Maura O'leary, Norma K.C. Ramsay, Mark E. Nesbit, David Hurd, William G. Woods, William Krivit, Tae H. Kim, Philip McGlave, John Kersey

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Allogeneic bone marrow transplantation was performed in 10 patients with disseminated Burkitt's lymphoma or poor-prognosis T-cell lymphoblastic lymphoma. All patients received a cytoreduction regimen consisting of cyclophosphamide, cytosine arabinoside, bis-chloro-nitroso-urea, and total-body irradiation. Eight patients received marrow from HLA-matched sibling donors. One patient received marrow from a parent donor and one patient died during initial cytoreduction and did not undergo total-body irradiation or marrow infusion. Six patients had Burkitt's lymphoma stages III and IV at diagnosis, and three of the six are alive at 18, 28, and 73 months. Four patients had T-cell lymphoblastic lymphoma, stages III and IV at diagnosis, and two of the four are alive at 29 and 49 months. Overall survival in the nine patients who underwent transplantation is 56 percent by life-table analysis. Follow up for the surviving patients ranges from 18 to 73 months (median 29 months). All five survivors are at home with unmaintained remissions.

Original languageEnglish (US)
Pages (from-to)497-501
Number of pages5
JournalThe American Journal of Medicine
Volume74
Issue number3
DOIs
StatePublished - Mar 1983

Fingerprint Dive into the research topics of 'Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults. A pilot study'. Together they form a unique fingerprint.

Cite this